NSCLC Isotoxic Hypofractionated Chemoradiotherapy

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2026

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
RADIATION

isotoxic hypofractionated group

the normal tissue limits are uniform, such as: V20% ≤ 30%, spinal cord 0\> 45Gy, etc., and used hypofractionated radiotherapy technology so that each patient received the maximum individualized radiation dose as possible,and the same time use the Platinum-containing drugs: docetaxel + lobaplatin Docetaxel 60 mg/m2, d1; Lobaplatin 30 mg/m2, d1, repeated every 28 days. The first cycle of chemotherapy started on the first day of radiotherapy.Consolidate chemotherapy up to 4 cycles after radiotherapy, as above.

Trial Locations (1)

050000

RECRUITING

The Second Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

The Second Hospital of Hebei Medical University

OTHER